Autolus Therapeutics (AUTL) Gross Profit (2024 - 2025)

Autolus Therapeutics (AUTL) posted quarterly Gross Profit of -$1.0 million for Q4 2025, up 90.83% year-on-year from -$545498.4 in Q4 2024, and up 86.02% on a QoQ basis from -$7.4 million in Q3 2025.

Autolus Therapeutics (AUTL) Gross Profit (2024 - 2025) Analysis & Trends

Autolus Therapeutics (AUTL) has reported Gross Profit for 2 consecutive years, with -$1.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Gross Profit rose 90.83% year-over-year to -$1.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.0 million (down 1567.81% YoY) and the FY2025 annual result came in at -$21.0 million, down 1555.96% from the prior year.
  • Gross Profit grew to -$1.0 million in Q4 2025 per AUTL's latest filing, from -$7.4 million in the prior quarter.
  • Over the last five years, Gross Profit for AUTL reached as high as $10.1 million in Q1 2024 and fell as low as -$11.4 million in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Autolus Therapeutics 404.53 Mn 103.82 Mn -1.04 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.04 Mn
Dec 31, 2025 -1.04 Mn
Sep 30, 2025 -7.45 Mn
Sep 30, 2025 -7.45 Mn
Jun 30, 2025 -3.52 Mn
Jun 30, 2025 -3.52 Mn
Mar 31, 2025 -8.97 Mn
Mar 31, 2025 -8.97 Mn
Dec 31, 2024 -11.36 Mn
Dec 31, 2024 -11.36 Mn
Mar 31, 2024 10.10 Mn
Mar 31, 2024 10.10 Mn